- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 285 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 183 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- November 2025
- 200 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Clinical Trials
- May 2026
- 180 Pages
Global
From €1790EUR$2,000USD£1,530GBP
- Report
- March 2026
- 30 Pages
Global
From €2461EUR$2,750USD£2,104GBP
- Report
- December 2025
- 200 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Report
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Report
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,134GBP
- Report
- May 2026
- 200 Pages
Global
From €2495EUR$2,789USD£2,134GBP

Cyclophosphamide is a drug used to treat immune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. It is a type of alkylating agent, which works by inhibiting the growth of certain cells in the body. It is usually administered intravenously or orally, and is often used in combination with other drugs. Cyclophosphamide is also used to treat certain types of cancer, such as lymphoma and leukemia.
Cyclophosphamide is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as bone marrow suppression, and should be used with caution.
Some of the companies in the Cyclophosphamide market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more